Pharmafile Logo
Pharmafocus logo
Advanced Search

Vioxx

Showing 8 posts of 8 posts found.

Vioxx image

Merck pays $37m to settle Canadian Vioxx claims

January 23, 2012
Sales and Marketing Canada, Merck, Vioxx

Merck will pay a maximum of C$37 million to settle all claims against its painkiller Vioxx in Canada.  The settlement …

News
Vioxx

Merck pays $950 million to settle Vioxx charges

November 23, 2011
Sales and Marketing Department of Justice, Merck, Vioxx, marketing violations, off label marketing

Merck will pay out $950 million and admit that it illegally marketed its painkiller Vioxx in the US. It will …

News

Drug regulators protect profits over patients, new study finds

May 11, 2011
Research and Development Bad Science, Vioxx, regulatory affairs

Medicine regulators are protecting drug company profits over the welfare of patients by withholding trial data. That’s the verdict of …

News

Investors get green light to continue Merck lawsuit

April 29, 2010
Merck, Vioxx

Investors suing Merck over ‘omissions and misstatements’ relating to its arthritis pain drug Vioxx will be allowed to continue with …

News

Merck to pay $4.9 billion to end Vioxx claims

November 15, 2007
Sales and Marketing Vioxx, safety

Merck looks set to pay $4.9 billion in a settlement for the thousands of people claiming injury after taking its …

News

The weight of evidence – the stories that changed pharma in 2004

January 4, 2005
Research and Development 2004, Vioxx, year in review

Ticking time bombsIn 2004, countries around the world faced up to some home truths about the health of their populations …

Feature

Lonngren lashes out at late warning

November 1, 2004
EMA, EMEA, Lonngren, Vioxx

 Thomas Lonngren, the head of Europe’s medicines regulator the EMEA has spoken out about Merck’s withdrawal of Vioxx, saying the …

News

Markets stunned as Merck withdraws blockbuster Vioxx

September 30, 2004
Merck, Vioxx

Merck has taken the pharmaceutical world by surprise by announcing the immediate withdrawal of its blockbuster arthritis pain drug Vioxx …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025